| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |